To prove a GLP-1 drugs personal injury, crucial evidence includes comprehensive medical records detailing your diagnosis, treatment, and prognosis of the severe side effect (e.g., gastroparesis, gallbladder disease)
In most cases they found the injections to not be a problem upon initiation
A 2023 systematic review examined three clinical trials including almost 460 participants with NAFLD
That's what happened in the case of new weight-loss drugs, known as GLP-1 agonists, that have exploded in popularity in the past couple of years
Discard the pen if you notice cloudiness, visible particles, discolouration, crystallisation, or any damage to the device, as these indicate the medication is no longer safe to use
ABLM Board Certified in Lifestyle Medicine Vinita Tandon, MD, ABIM Board Certified in Endocrinology and Metabolism